A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
Dry and cold. Patchy frost and fog. Good dose of sunshine into Sunday. Kerrie has the detail for the next few days....
Communities say they are still waiting for emergency funding to restore their homes and agricultural land.
A woman is in a critical condition in hospital after she was hit by a taxi in the early hours of Saturday, December 3.